Levormeloxifene fumarate structure
|
Common Name | Levormeloxifene fumarate | ||
---|---|---|---|---|
CAS Number | 199583-01-2 | Molecular Weight | 573.67600 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C34H39NO7 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Levormeloxifene fumarateLevormeloxifene (fumarate) is a stable salt form of Levormeloxifene. Levormeloxifene (fumarate) is an estrogen receptor modulator that plays an important role in prevention of postmenopausal bone loss[1]. |
Name | (E)-but-2-enedioic acid,1-[2-[4-[(3R,4R)-7-methoxy-2,2-dimethyl-3-phenyl-3,4-dihydrochromen-4-yl]phenoxy]ethyl]pyrrolidine |
---|---|
Synonym | More Synonyms |
Description | Levormeloxifene (fumarate) is a stable salt form of Levormeloxifene. Levormeloxifene (fumarate) is an estrogen receptor modulator that plays an important role in prevention of postmenopausal bone loss[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C34H39NO7 |
---|---|
Molecular Weight | 573.67600 |
Exact Mass | 573.27300 |
PSA | 105.53000 |
LogP | 5.90620 |
Levormeloxifene fumarate (JAN) |
Pyrrolidine,1-(2-(4-((3R,4R)-3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl)-,(2E)-2-butenedioate (1:1) |
UNII-2XFK7X56Q3 |
Levormeloxifene fumarate |